Published in Cancer Weekly, June 29th, 1998
D.N.J. Hart, representing colleagues from the Christchurch Hospital, Christchurch, New Zealand, explained the process at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Development of a Method for Monitoring Blood Dendritic Cell Numbers: Comparison of Normal Individuals and Patients Undergoing Stem Cell Mobilization").
"The aim of this work was to develop a flow cytometric method to assay DC numbers using the CMRF44 antibody to identify DC after blood mononuclear cells (MNC) had been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.